Atlas Trials

A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment

Clinical trial NCT04560244 · UNKNOWN

Trial details

NCT number
NCT04560244
Sponsor
Shandong Cancer Hospital and Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer
Start date
2020-09-01
Primary completion
2022-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.